RxDoctor Payments Data

Michael Bradley, DO

Family Medicine · Pine Grove, PANPI 1609981992

Payments from drug & device makers

$2,528in general payments, 2019–2025

Across 143 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$804
  • Novo Nordisk$393
  • Amgen$239
  • Lilly USA, LLC$229
  • Pfizer$182
  • Novartis$138
  • plus $544 from 13 others

What the payments were for

  • Food & beverage$2,517100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,528 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$235,106
Medicare patients
248
Services billed
4,583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$77,791
EliquisApixaban107$76,621
FarxigaDapagliflozin Propanediol53$53,677
JardianceEmpagliflozin43$44,368
XareltoRivaroxaban33$40,551
TrulicityDulaglutide17$36,582
JanuviaSitagliptin Phosphate29$33,225
AbrysvoRsv Vacc, Pref A And Pref B/Pf64$20,302
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$12,666
TradjentaLinagliptin17$12,374
RybelsusSemaglutide11$10,163
EntrestoSacubitril/Valsartan12$8,154
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$5,466
Atorvastatin Calcium326$5,204
Metoprolol Succinate245$4,466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$182$96,923171 claims
Novo NordiskOzempic, Rybelsus$393$87,95475 claims
Boehringer IngelheimJardiance, Tradjenta$82$56,74260 claims
AstraZenecaFarxiga$42$53,67753 claims
Johnson & JohnsonXarelto$70$40,55133 claims
Lilly USA, LLCTrulicity$229$36,58217 claims
MerckJanuvia$14$33,22529 claims
NovartisEntresto$138$8,15412 claims
GSKBreo Ellipta$59$4,39112 claims
AbbVieSynthroid$804$1,93263 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Pine Grove

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →